Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Short term Debt (2016 - 2025)

Angiodynamics' Short term Debt history spans 14 years, with the latest figure at $5.0 million for Q1 2025.

  • For Q1 2025, Short term Debt fell 47.37% year-over-year to $5.0 million; the TTM value through Feb 2025 reached $5.0 million, down 47.37%, while the annual FY2024 figure was $4.7 million, 67.97% down from the prior year.
  • Short term Debt reached $5.0 million in Q1 2025 per ANGO's latest filing, up from $5.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $14.8 million in Q2 2023 to a low of $4.7 million in Q2 2024.
  • Average Short term Debt over 4 years is $7.9 million, with a median of $8.8 million recorded in 2022.
  • Peak YoY movement for Short term Debt: soared 68.06% in 2023, then plummeted 67.97% in 2024.
  • A 4-year view of Short term Debt shows it stood at $9.8 million in 2022, then fell by 3.82% to $9.4 million in 2023, then crashed by 47.16% to $5.0 million in 2024, then rose by 0.81% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for ANGO's Short term Debt are $5.0 million (Q1 2025), $5.0 million (Q4 2024), and $4.8 million (Q3 2024).